Last reviewed · How we verify
NCT03530189
Outcome of Very Preterm Infants With Glucose Level Disturbances
trial testing 10% dextrose in Cerebral Palsy Infantile in 150 participants. Completed in 31 December 2022.
31 December 2022
Quick facts
| Lead sponsor | University Hospital Rijeka |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 150 |
| Start date | 1 January 2018 |
| Primary completion | 31 December 2022 |
| Estimated completion | 31 December 2022 |
| Sites | 1 location across Croatia |
Drugs / interventions tested
- 10% dextrose
- bolus of dextrose, reducing the glucose infusion, insulin — full drug profile →
Conditions studied
- Cerebral Palsy Infantile — all drugs for Cerebral Palsy Infantile →
Sponsor
University Hospital Rijeka
Who can join
Adults 24 Weeks to 27 Months, any sex, with Cerebral Palsy Infantile. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The hypothesis of this prospective, cohort study is that hyperglycemia, hypoglycemia and unstable glucose levels in the first seven days of life in infants born very preterm and at very low birth weights can harm long-term neurodevelopment. The objective of the study is to investigate the relationship between early neonatal glycemia, neonatal characteristics, and developmental outcomes in preterm infants. All infants born before 32. gestational week or below 1500 g admitted to the neonatal intensive care unit will be included in the study. According to the glucose values, the infants will be divided into the normoglycemic group and the group with disturbed glucose concentration. In the corrected age of two neurodevelopmental outcome will be assessed and categorized as normal, mild, moderate or severe impairment. Since the results of published studies about the effects of asymptomatic neonatal hypoglycemia and hyperglycemia on neurodevelopment are inconsistent, the correlation between early disturbances in glucose levels and neurodevelopmental outcome will be assessed.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03530189
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of 10% dextrose
Trials testing the same drug.
- NCT07233382 — Assessing the Efficacy of Probiotics in Prevention of NEC in Preterm Babies · NA · not yet recruiting
Other recruiting trials for Cerebral Palsy Infantile
Currently open trials in the same condition.
- NCT07493096 — Intensive Multimodal Neurorehabilitation Targeting Neuroplasticity in Pediatric Neurodevelopmental and Chromosomal Disor · recruiting
- NCT06807203 — Motor-voice Assessment in Infants (MAMI) · recruiting
- NCT06947889 — Biofeedback Based System to Enhance Robotic Assisted Gait Training in Children With Cerebral Palsy · recruiting
Other University Hospital Rijeka trials
Trials by the same sponsor.
- NCT06236360 — Metastatic Melanoma Patients on Immunotherapy With Nutritive Intervention Based on Mediterranean Diet · NA · unknown
- NCT04760353 — The Effect of a Probiotic Mixture in Obese Patients With Irritable Bowel Syndrome · NA · completed
- NCT04688645 — Balanced Crystalloid Solutions for Acute Pancreatitis · Phase 4 · unknown
- NCT04532476 — Effect of a Double Dose of Photobiomodulaton Therapy on Orthodonthic Pain Caused by Elastomeric Separators · NA · completed
- NCT04038853 — Vitamin D in Fatty Liver Disease · Phase 4 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03530189 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Hospital Rijeka
- Last refreshed: 29 August 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03530189.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing